| Host: |
Mouse |
| Applications: |
ELISA |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Mouse monoclonal antibody anti-FABP3 is suitable for use in ELISA research applications. |
| Clonality: |
Monoclonal |
| Clone ID: |
2303 |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG1 |
| Formulation: |
50 mM Na-citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| Purification: |
Greater than 95% purity |
| Concentration: |
5.0 mg/ml (+/-10 %) |
| Storage Instruction: |
24 months from manufacturing at 2–8°C. Temperature analysis:-70 °C, 21 days N/D-20 °C, 21 days OK +4 °C, 21 days OK +30 °C, 21 OK +35 °C, 21 days OK +45 °C, 7 days OK. Shelf life stability testing at 2–8 °C in the product buffer. |
| Association Rate Constant: |
8.9 x 105 1/Ms |
| Determination Method: |
SPR analysis (ProteOn XPR36) |
| Immunoreactivity: |
80–120 % compared to the reference sample in an FIA test |
| Gene Symbol: |
FABP3 |
| Gene ID: |
2170 |
| Uniprot ID: |
FABPH_HUMAN |
| Immunogen: |
Human fatty acid binding protein 3 (FABP3) |
| Function | FABPs are thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters. |
| Protein Name | Fatty Acid-Binding Protein - HeartFatty Acid-Binding Protein 3Heart-Type Fatty Acid-Binding ProteinH-FabpMammary-Derived Growth InhibitorMdgiMuscle Fatty Acid-Binding ProteinM-Fabp |
| Database Links | Reactome: R-HSA-163560 |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-Fatty Acid-Binding Protein - Heart antibodyAnti-Fatty Acid-Binding Protein 3 antibodyAnti-Heart-Type Fatty Acid-Binding Protein antibodyAnti-H-Fabp antibodyAnti-Mammary-Derived Growth Inhibitor antibodyAnti-Mdgi antibodyAnti-Muscle Fatty Acid-Binding Protein antibodyAnti-M-Fabp antibodyAnti-FABP3 antibodyAnti-FABP11 antibodyAnti-MDGI antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
